IRADIMED CORP — Director's Dealing 2021

Nov 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-11-23

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-23	Common Stock	A	6038	$1.48	Acquired	23306	Direct
2021-11-23	Common Stock	S	6038	$41.2025	Disposed	17268	Direct
2021-11-24	Common Stock	A	37454	$1.48	Acquired	54722	Direct
2021-11-24	Common Stock	S	37454	$42.9526	Disposed	17268	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-23	Stock Options (Right to Buy)	$1.48	M	6038	Disposed	2023-12-31	Common Stock (6038)	Direct
2021-11-24	Stock Options (Right to Buy)	$1.48	M	37454	Disposed	2023-12-31	Common Stock (37454)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

F2: This transaction was executed in multiple trades at prices ranging from $41.20 to $41.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $42.25 to $44.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.